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ABSTRACT 
Aims: To determine the prevalence of glaucoma within the indigenous Australian 
population living in central Australia. 
Methods: 1,884 individuals aged ≥20 years, living in one of 30 remote communities 
within the statistical local area of ‘Central Australia’ were recruited for this study. 
This equated to 36% of those aged ≥20 years and 67% of those aged ≥40 years within 
this district. Slit-lamp examination of the anterior segment and intraocular pressure 
measurement, followed by stereoscopic slit-lamp fundoscopy of the optic nerve was 
performed. Selected patients underwent automated visual field testing. The diagnosis 
of glaucoma was based on pre-existing definitions. Glaucoma prevalence data are 
presented. 
Results: Seventeen individuals had glaucoma (0.90%). Causes of secondary 
glaucoma were found in 4 with neovascular glaucoma, 2 with uveitic glaucoma and 4 
who had developed glaucoma subsequent to trauma or surgery. The remaining 7 had 
no identifiable cause for their glaucoma and were thus classified as open-angle 
glaucoma equating to a prevalence of 0.52% (95% C.I 0.14 to 0.90) for those aged 
≥40 years. Of these, 4 had an IOP ≤21 mmHg and 3 had an IOP >21 mmHg. 
Conclusion: The prevalence of open-angle glaucoma among indigenous Australians 
within central Australia was 0.52% for those aged ≥40 years. After adjustment for the 
age distribution of our sample, this is one third the prevalence seen among the non-
indigenous Australian population and is despite a higher prevalence of ocular 
parameters considered to be associated with glaucoma.
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Glaucoma is a major cause of blindness worldwide.[1] In Australia, glaucoma is the 
second most common cause of blindness after age-related macular degeneration.[2] It 
increases in prevalence with age[3-5] and shows a strong association with a known 
family history of glaucoma[5-7] and the presence of ocular conditions such as 
pseudoexfoliation syndrome (XFS)[8] or pigment dispersion syndrome.[9] Prevalence 
of open-angle glaucoma (OAG) varies considerably among different racial groups, 
occurring in 2.1% of white populations, 1.4% of Asian populations, and 4.2% of black 
populations for those age 40 years and older.[10] 
Within the non-indigenous Australian population the prevalence of OAG been 
estimated at 1.7% of those aged 40 years[3] or older and 3.0% of those aged 49 years 
or older.[4] However, indigenous Australians have been felt to have a much lower 
prevalence,[11] with previous work performed by the National Trachoma and Eye 
Health Project (NTEHP) in the 1970s finding a rate of only 0.4% among those aged 
40 years or older.[12] This is despite other studies finding a high frequency of 
XFS,[12,13] thinner central corneal thickness (CCT)[14,15] and larger optic discs and 
cup/disc ratios[16,17] among indigenous Australians. 
During the Central Australian Ocular Health Study, we aimed to perform a 
comprehensive enumeration of the current ocular morbidity among indigenous 
Australians living within central Australia. This paper was designed to determine the 
prevalence and sub-types of glaucoma within this population. 
 
METHODS 
 
The Central Australian Ocular Health Study took place in 30 remote 
communities within the statistical local area of ‘central Australia’, excluding those 
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living in and around the city of Alice Springs (Figure 1). Clinics were held at each of 
these communities a total of once or twice per year depending on the population of 
the community. Given the length of time between each of these clinics, the health 
workers in the communities would actively encourage every resident to attend the 
clinics regardless of their symptoms. 
Patients were recruited from those who identified themselves as indigenous 
Australians, presenting to the remote clinics at each of these communities during the 
36 month period between July 2005 and June 2008. Ethical approval from the Central 
Australian Human Research Ethics Committee was obtained and conformed to the 
tenets of the Declaration of Helsinki. The aims of the study were explained, with an 
interpreter whenever necessary and written informed consent was obtained. Data were 
entered on a standardized form which had been constructed prior to the 
commencement of the study. All data collection was performed under the supervision 
of one of two experienced consultant ophthalmologists. 
Following visual acuity testing using a tumbling E acuity chart at 3 metres in a 
well-lit room, intraocular pressure was performed using either a Perkins tonometer 
(Haag-Streit, Koeniz, Switzerland) or an ICare tonometer (Tiolat Oy, Helsinki, 
Finland) depending on the availability of equipment. A slit-lamp examination of the 
anterior segment was performed, followed by a pupil examination performed with a 
hand torch. An assessment of the anterior chamber depth was then made using the 
‘oblique flashlight test’,[18] however gonioscopy was not performed. The pupils were 
dilated with tropicamide 1.0% and phenylephrine 2.5%, unless the anterior chamber 
was found to be shallow in which case only tropicamide 1.0% was used. The anterior 
surface of the lens capsule was examined for the presence of XFS, followed by an 
examination of the lens with grading using the modified Lens Opacities Classification 
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System III.[19] Finally, stereoscopic slitlamp fundoscopy of the optic nerve, the 
posterior pole and the peripheral retina was performed using a 90D fundoscopy lens. 
If indicated based on clinical suspicion of glaucoma, visual field testing was 
performed using either a screening C20-1 algorithm on a Frequency Doubling 
Perimeter (FDP)(Carl Zeiss, Dublin, CA, USA), or a SITA-fast algorithm on a 
Humphrey Field Analyzer II (HFA)(Carl Zeiss, Dublin, CA, USA). A field was 
considered unreliable if either false-positive errors, false-negative errors, or fixation 
losses were greater than 33%.[20] An abnormal field using FDP was one in which 
there were 2 or more adjacent non-central abnormal zones of P<1% or worse, with at 
least 2 zones of P<1% or worse, or one zone of  P<0.5% or worse touching the 
horizontal nasal meridian.[21,22] Visual field loss was considered significant on the 
HFA if it had a pattern typical of glaucoma and occurred in a field with five or more 
non-rim points of P<5%, with a cluster in a nasal quadrant of at least three abnormal 
points of P<5%, or at least two points of P<1%.[3] 
The presence of glaucoma was defined under the guidelines according to 
Foster et al.[23] Due to the logistics of ocular healthcare delivery to this remote area, 
a visual field perimeter was not available on a number of occasions. Therefore, case 
identification was undertaken in the following way (Figure 2): Participants were 
examined for the presence the neuroretinal rim width reduced to <0.1 CDR (between 
11 to 1 o’clock or 5 to 7 o’clock) or the presence of a CDR ≥ 97.5th percentile.[23] 
This equated to ≥0.7 due to the large vertical disc size and consequently large CDR 
possessed by indigenous Australians.[16] When present, the participant was 
considered for a visual field test. When this was possible, the participant was then 
assessed under category 1 criteria (disc criteria as above and a definite visual field 
defect consistent with glaucoma). When perimetry was not possible, glaucoma was 
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considered to be present if category 2 criteria were fulfilled (CDR ≥99.5th percentile 
(i.e ≥0.8)[16] in the absence of any other explanation) or if category 3 criteria were 
fulfilled when disc assessment was not possible (visual acuity <3/60 and IOP >99.5th 
percentile (24 mmHg)[24], or visual acuity <3/60 and the eye shows evidence of 
glaucoma filtering surgery, or medical records confirm glaucoma).  
Finally, we presented data regarding those who were considered to be 
glaucoma suspects,[23] which were defined as: Those with a CDR ≥0.7 but <0.8 who 
either had no visual field loss or did not undergo visual field testing, those with optic 
disc margin haemorrhages in the presence of a normal optic disc and normal IOP, 
those with an IOP >97.5th percentile (21mmHg)[24], those with XFS and those with a 
positive oblique flashlight test but normal optic disc, visual field and IOP.  
Based on previous work,[14,16,25] which established the likely demographics 
of patients presenting to the remote clinics and the likely prevalence of ocular 
disorders,[12] our aim was to enrol at least 1850 patients aged 20 years or older into 
the study, in order to ensure that at least 1200 patients aged 40 years or older were 
enrolled. This would allow the detection of the least prevalent major ocular disorder 
(glaucoma) at an expected prevalence of 0.4%.[12]  
Statistical Analysis System 9.1 (SAS Institute Inc, Cary, NC) was used for 
statistical analysis including descriptive statistics, student t-test, and logistic 
regression. Age was considered as a continuous variable. The presence of a positive 
oblique flashlight test, sex, diabetes and hypertension were considered as categorical 
variables. Test statistics, 95% confidence intervals and p values are presented. 
Confidence intervals for prevalence estimates were derived using a normal 
approximation interval of a binomial distribution. A p value of <0.05 was considered 
statistically significant. 
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RESULTS 
From the 5,173 persons who were in the target population, we recruited 1,884 
during the 36 month period of the study. This included 689 (36.6%) males and 1195 
(63.4%) females, the average age of which were 49 years (SD 14yrs) for males and 48 
years (SD 15yrs) for females (t=1.58; P=0.11). This represented 36% (1884/5173) of 
the total and 67% (1347/2014) of those aged 40 years and older.  
 1394 patients underwent optic disc assessment and were assessed under 
category 1 and 2 criteria and 490 patients could not undergo optic disc assessment due 
to media opacity and therefore were assessed under category 3 criteria (Figure 2). 
Twenty-four of these could not have their anterior chambers assessed due to 
enucleation, phthisis, or severe corneal scarring. 
From the total, there were 17 patients (0.90%, 95% C.I 0.40 to 1.20) who had 
glaucoma, 15 of those were aged 40 years or older (1.11%, 95% C.I 0.55 to 1.67). The 
17 patients included 4 with neovascular glaucoma, 2 with uveitic glaucoma and 4 who 
had developed glaucoma subsequent to trauma or surgery. The remaining 7 from the 
original sample of 1884 (0.37%) had no identifiable cause for their glaucoma 
including a negative oblique flashlight test, equating to a prevalence of open-angle 
glaucoma of 0.52% (95% C.I 0.14 to 0.90)(7/1347) for those aged 40 years or older 
(Figure 3). After adjusting for the age distribution of our sample, the prevalence of 
open-angle glaucoma varied from 0.57% (95% C.I 0.17 to 0.97)[3] to 1.01% (95% C.I 
0.36 to 1.66)[4] depending on the non-indigenous Australian population used in the 
comparison. Of those who had open-angle glaucoma, 4 had an IOP ≤21 mmHg and 3 
had an IOP >21 mmHg. Four were female and 3 were male. There was an increase in 
prevalence of open-angle glaucoma with increasing age (Figure 4).  
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There were 137 patients who were considered glaucoma suspects. These 
included 28 with CDR ≥0.7 but <0.8 with no definite signs of glaucoma and an IOP 
<21 mmHg, 71 with XFS but with an IOP <21mmHg and a normal optic nerve, 14 
with an IOP >24 mmHg but no glaucomatous optic neuropathy (GON), 1 patient with 
a disc margin haemorrhage but an IOP of 13 mmHg and a CDR of 0.4 and 1 patient 
with XFS and a CDR of 0.7 without focal changes consistent with glaucoma and an 
IOP of 12mmHg.  Furthermore, we found 22 (1.3%) patients with a positive oblique 
flash-light test in one or both eyes (1.7% of those aged 40 years or older), but without 
any evidence of raised IOP or GON. The prevalence of a positive oblique flashlight 
test increased with advancing age although this did not reach statistical significance 
(t=1.68; P=0.09). Furthermore, the presence of a positive oblique flashlight test was 
not associated with sex, diabetes or hypertension. 
 
DISCUSSION 
Glaucoma is a condition which is seen to affect all populations around the 
world. However, its prevalence can vary widely between racial groups. Amongst non-
indigenous Australians, the prevalence of open-angle glaucoma has been estimated at 
between 1.7%[3] and 3.0%.[4] We found a prevalence of glaucoma among indigenous 
Australians of 0.52%. After adjustment for the age distribution of our sample, this 
increased marginally to 0.57% (for those ≥40 years old) when the Vision Impairment 
Study3 was used in the comparison and 1.01% (for those ≥49 years old) when the 
Blue Mountains Eye Study[4] was used. This equates to one third of the prevalence 
found among non-indigenous Australians and is similar in magnitude to the rates of 
0.4% for indigenous Australians and 1.5% for non-indigenous Australians found by 
the NTEHP.[12] 
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These findings are significant for a number of reasons. The variation in 
prevalence of glaucoma between different races has been hypothesized to be caused 
by risk factors associated with glaucoma, such as CCT,[26] optic disc size or 
CDR[27,28] and XFS.[8] However, given that indigenous Australians CCT is 
significantly thinner than other racial groups,[16,17] their optic disc size is 
significantly larger than other racial groups[14,15] and XFS is significantly more 
prevalent than other racial groups,[12,13] these factors would predict a significantly 
greater prevalence of glaucoma. However, if we were to assume that these risk factors 
did not contribute to the variation in OAG prevalence between races then, it may be 
that other genetic or possibly environmental factors have exerted a protective effect 
on indigenous Australians. This may be demonstrated by a direct comparison of 
genetic profiles between groups of indigenous Australians, Caucasians and black 
Africans.  
Our study is limited by the method through which the sample was recruited. 
As patients need to voluntarily present to an eye clinic, there is the potential that the 
prevalence of ocular disorders within this sample may be over-represented. However, 
visits to these remote communities occurred only once or twice per year, therefore the 
health workers in the communities would actively encourage every resident to attend 
the clinics regardless of their symptoms. The majority presented for a ‘check-up’ and 
not due to symptoms, therefore the data collected should reflect the current prevalence 
of glaucoma within this indigenous population. As males are less likely to present to a 
health professional,[29] almost twice as many females as males were recruited. This 
phenomenon has been observed in previous work involving non-indigenous 
populations[30] and there is evidence that it may translate over to the indigenous 
Australian population.[31,32] However, glaucoma was not associated with sex, 
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therefore this gender imbalance that decreased in older age groups, should not have 
affected our results. We collected data on 36% of the population within the central 
Australian statistical subdivision who were aged 20 years or older and this recruitment 
increased with age, such that 67% of those aged 40 years or older were included. 
Although glaucoma was associated with advancing age, we feel that estimates of 
visual impairment among those aged 40 years or older should reflect the true 
prevalence of visual impairment within this age group. Our work was based on the 
findings from two different tonometers (an ICare tonometer and a Perkins tonometer), 
which may have affected the results. The selection of a tonometer was based on the 
availability of the equipment in the remote locations and was not dependent on any 
aspect of the patient. ICare rebound tonometry has been validated as a good and 
reliable alternative to applanation tonometry, however, it has been reported in some 
studies to measure a higher IOP reading, with the average over-estimation being up to 
2.0 mmHg (SD 3.0).[33-39] Despite this, we found no statistically significant 
difference between the readings from the group measured with Perkins tonometry 
compared with those from the group measured with ICare tonometry.[24] Ideally, all 
patients should have had perimetry. Those who underwent visual field testing were 
assessed under category 1 criteria, among which 20% (3/17) were found to have 
glaucoma (Figure 2). However there was a group for whom perimetry was not 
possible and these patients were assessed under category 2 criteria. Among this 
second group, 27% (10/37) were found to have glaucoma (Figure 2), although given 
the results from those assessed under category 1 criteria, we might have expected only 
20% of the second group (7/37) to have been diagnosed with glaucoma had they also 
undergone visual field testing. Therefore, had perimetry been possible for all patients, 
the prevalence estimate of glaucoma might have been less. It is possible that those 
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assessed under category 3 criteria had only ocular hypertension and not glaucoma, 
thereby resulting in a total prevalence for glaucoma of only 0.69% (95% C.I 0.32 to 
1.06%). Although we feel this was unlikely given that these patients either had 
rubeosis or penetrating trauma with IOP ranging from 31 to 47 mmHg. Gonioscopy 
was not performed, however we used the oblique flashlight test to exclude those with 
occludable anterior chamber angles.[18] Although we found a positive flashlight test 
in 1.7% of individuals, none of these had any form of glaucoma. This test has been 
reported to have a negative predictive value of between 94% and 98% for the 
detection of occludable angles (at least 3 quadrants where the posterior trabecular 
meshwork is obscured)[40,41] and thus, those found to have a negative flashlight test 
would have been unlikely to have had angle closure. Lastly, the estimation of CDR 
was determined clinically. We had performed a pilot study prior to this survey in 
order to determine the likely range of CDR and inform the clinicians about the 
expected appearance of optic discs among this population.[16] Furthermore, all data 
collection was performed under the supervision of one of two experienced consultant 
ophthalmologists, which would have minimised inter-observer error. 
We have found that the prevalence of open-angle glaucoma for indigenous 
Australians was between one third to one quarter the prevalence of that found within 
the non-indigenous Australian population. This was despite the sample having ocular 
parameters which are considered to be associated with a higher risk of glaucoma (i.e 
XFS, thinner CCT and larger optic disc size and CDR). Other as yet unidentified 
genetic or environmental factors may be protective for the development of glaucoma 
among indigenous Australians.  
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FIGURE LEGEND 
 
Figure 1. Schematic map of the central Australian statistical local area.  
(▲) Communities visited during the study. 
 
Figure 2. Diagnostic algorithm used to define glaucoma. 
 
Figure 3. Sample patients A and B who were found to have open-angle glaucoma. 
 
Figure 4. Prevalence of open-angle glaucoma by age. 
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